SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-012555
Filing Date
2018-11-13
Accepted
2018-11-13 17:29:45
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT mbvx10q_09302018.htm 10-Q 940295
2 ASSET PURCHASE AND LICENSE AGREEMENT ex10-1.htm EX-10.1 566679
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31 13024
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 12939
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32.htm EX-32 11044
6 IMAGE ex10-1000.jpg GRAPHIC 3946
  Complete submission text file 0001654954-18-012555.txt   3825412

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mbvx-20180930.xml EX-101.INS 429038
8 XBRL TAXONOMY EXTENSION SCHEMA mbvx-20180930.xsd EX-101.SCH 35054
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbvx-20180930_cal.xml EX-101.CAL 51267
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbvx-20180930_def.xml EX-101.DEF 90812
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbvx-20180930_lab.xml EX-101.LAB 245152
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbvx-20180930_pre.xml EX-101.PRE 196013
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37861 | Film No.: 181179328
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1